Friday, November 23, 2018 11:35:38 AM
My name, Esteban Charpentier DOB 08/21/1933.
I Have Trombocytopenia and have been treated at the Florida Cancer Specialists documented there) for over two or more years.
Have been on NPlate also for a while, Dr. Marte is my oncologist. She told me about Tavalisse and its Plusses
So decide to go with it.
Started with the first pill on AM 10/17/18 , following day I had chest pains and not feeling good, was attributed to
my arthritis, but continued to feel bad and be disconfored.
On Sunday 10/28/18 drove to the supermarket and been there got a bad feeling on my chest, thought was having a heart attack
Got in the car to go back home but on the way blacked out and had an accident.
Was taken to St Joseph’s hospital Emergency Services, they did a full exam , Scan’s , Blood ETC.
For what I understand they did not find anything wrong with me.
Tavalisse was suspended immediately, By that time I had taken 23 pills. Have the rest of33 pills left at home)
As Tavalisse was suspended, I started to feel normal and have been without it, I am going back on NPlate.
On 11/13/18 got the first shot of 50mg to put me back on it. When I stopped it I was on 103mg a week.
I still feel normal after stopping the Tavalisse.
This episode with the Tavalise destroy my car, so cannot drive so have to use taxis to move, very expensive for a
Person on only social security so I am on a bind.
I am going to repeat it again, I was feeling good before taking Tavalisse, started taking Tavalisse and all hell broke loose,
Stopped taking Tavalisse and have gone to feel normal again and going back on the previous medication NPlate.
Hope to get an answer as I have tried other channels and do not seem to go anywhere.
Sincerely,
Esteban Charpentier
charp1933@hotmail.com
Question, as soon as chest pains developed, should i have been withdrawn from the medication?
Recent RIGL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:16:15 PM
- Rigel Reports First Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 05/07/2024 08:01:00 PM
- Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update • PR Newswire (US) • 04/30/2024 12:05:00 PM
- Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 04/10/2024 08:30:00 PM
- Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma • PR Newswire (US) • 04/04/2024 12:05:00 PM
- Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer • PR Newswire (US) • 03/12/2024 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:10:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 09:06:00 PM
- Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • PR Newswire (US) • 03/05/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:16:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:15:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:15:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 12:14:43 AM
- Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update • PR Newswire (US) • 02/27/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 01:00:39 PM
- Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® • PR Newswire (US) • 02/22/2024 12:50:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:30:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:18:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:18:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:18:16 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/02/2024 02:56:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 02:17:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 02:17:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 02:17:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 02:16:50 AM
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM